Moloney Securities Asset Management, LLC Gilead Sciences, Inc. Transaction History
Moloney Securities Asset Management, LLC
- $714 Million
- Q3 2024
A detailed history of Moloney Securities Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 25,975 shares of GILD stock, worth $2.44 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
25,975
Previous 24,649
5.38%
Holding current value
$2.44 Million
Previous $1.69 Million
28.74%
% of portfolio
0.31%
Previous 0.25%
Shares
28 transactions
Others Institutions Holding GILD
# of Institutions
1,926Shares Held
992MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.8 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.19 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.81 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.65 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $118B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...